Recombinant VPS25 protein (His tag)

Recombinant VPS25 protein (His tag)

Cat.#: 543483

Size:

Special Price 294.7 USD

Availability: 3-4 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Recombinant VPS25 protein (His tag)
  • Documents
  • Description

    Recombinant human Vacuolar protein-sorting-associated protein 25 (hVps25) fragment (residues 1-176) is a high-quality protein designed for structural and biochemical studies. This fragment represents a stable, soluble unit of the ESCRT-II complex, essential for endosomal sorting and multivesicular body formation, offering researchers a reliable tool for investigating intracellular trafficking mechanisms.

    Vacuolar protein-sorting-associated protein 25 (hVps25) is a critical component of the ESCRT-II complex, which mediates endosomal sorting and multivesicular body (MVB) formation. This process facilitates the delivery of transmembrane proteins to lysosomes for degradation and plays roles in transcription regulation and viral budding. The full-length protein localizes to the cytoplasm, endosome membranes, and nucleoplasm, exhibiting a diffuse cytoplasmic and nuclear distribution with punctate patterns when coexpressed with CHMP6. The recombinant fragment (residues 1-176) encompasses the functional domain, enabling focused studies on its mechanistic contributions to cellular transport pathways.

  • Protein name
    Vacuolar protein-sorting-associated protein 25
  • Uniprot ID
    Q9BRG1
  • Gene Name
    VPS25; DERP9; EAP20
  • Source/Expression Host
    E. coli
  • Expression Plasmid/cDNA
    DNA encoding 1-176 aa (Q9BRG1) were fused with 6His tag.
  • Protein Species
    Human
  • Molecular weight
    Predictes a molecular mass of 22.40 kDa. In SDS-PAGE under reducing conditions, it migrates as an approximately 23 kDa band.
  • Purity
    >89%, by SDS-PAGE with Coomassie Brilliant Blue staining.
  • Activity
    Not tested.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"